Anh Tuan Nguyen
About Anh Tuan Nguyen
Anh Tuan Nguyen serves as the Vice President of Business Development at Slingshot Biosciences, where he has worked since 2011. He has over 15 years of experience in the life sciences sector, specializing in strategic partner management and business strategy, particularly in immunotherapy.
Current Role at Slingshot Biosciences
Anh Tuan Nguyen serves as the Vice President of Business Development at Slingshot Biosciences, a position he has held since 2022. In this role, he focuses on strategic partner management and business strategy, particularly within the immunotherapy sector. His responsibilities include overseeing business development initiatives and fostering relationships that support the company's growth objectives.
Previous Experience at Slingshot Biosciences
Prior to his current role, Anh Tuan Nguyen held multiple positions at Slingshot Biosciences. He worked as the Lead Strategy and Corporate Development from 2021 to 2022 and as Business Development and Operations from 2019 to 2021. His tenure at Slingshot has contributed to the company's strategic direction and operational efficiency.
Experience at Gilead Sciences
Anh Tuan Nguyen was employed at Gilead Sciences from 2014 to 2019, where he worked in Commercial Operations and Quality Assurance. His five-year experience at Gilead provided him with insights into the pharmaceutical industry and regulatory compliance, enhancing his expertise in the life sciences sector.
Educational Background
Anh Tuan Nguyen studied at Santa Clara University, where he earned a Bachelor of Science (BS) in Cell and Molecular Biology. He also completed minors in Biotechnology and Philosophy during his studies from 2002 to 2006. This diverse educational background has equipped him with a strong foundation in both scientific and analytical thinking.
Expertise in Life Sciences
With over 15 years of experience in the life sciences, Anh Tuan Nguyen specializes in flow cytometry, immunotherapies, and regulatory compliance. He possesses expertise in intellectual property development and has a strong background in founding and seeding life science businesses, contributing to his strategic insights in business development.